NEW FREEDOM, PA, November 02, 2018 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Frederic Marsik, Ph.D., with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Marsik celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Dr. Marsik, after graduating in 1965 from Lebanon Valley College, Annville, PA with a Bachelor of Arts in biology began his professional career at Memorial Sloan Kettering Research Institute working with Dr. Ernest Wynder on tobacco carcinogenicity. Dr. Wynder's work statistically and experimentally established that cigarette smoke causes cancer of the respiratory tract. From 1966 to 1968 Dr. Marsik worked at the Merck Institute of Research, Rahway, NJ where he was involved with the development of over the counter consumer products, developing thiabendazole as an antifungal drug, and researching indomethacin as a treatment for mycoplasma arthritis. While at the Institute, he developed an animal model of seborrhea dermatitis..
He then attended the University of Missouri School of Medicine (1968 to 1973) where he earned his Masters and Ph.D. in microbiology. For his Masters Degree Dr. Marsik showed that strains of Escherichia coli associated with urinary tract infections could be identified with bacteriophages. His Ph.D. work was done in conjunction with the University of Missouri School of Veterinary Medicine and the Food and Drug Administration (FDA). The work showed that antimicrobials in animal feed brought about the development of antimicrobial-resistant bacteria in livestock which could be transferred to humans associated with the livestock. In addition, Dr. Marsik was among the first to recognize that Staphylococcus epidermidis can cause deadly human infections and that certain antibiotics could alter the expression of its virulence factors. Dr. Marsik's graduate work won him the first Department of Microbiology award and he was inducted into Sigma Xi.
After completing his Ph.D. work, Dr. Marsik did a post-doc in clinical microbiology at Hartford Hospital in Hartford Connecticut (1973 to 1976). During his post-doc Dr. Marsik was involved in the description of the first ampicillin-resistant Haemophilus influenzae infections in a community population and was part of team that described the first methicillin-resistant Staphylococcus aureus outbreak in a large United States community hospital. Upon completion of his post-doc he became certified by the American Board of Medical Microbiology in Clinical and Public Health Microbiology.
From 1976 to 1980 Dr. Marsik was Assistant Director of the microbiology laboratory and Assistant Professor of Pathology at the University of Virginia School of Medicine. His work contributed to the microbiology laboratory receiving its first American Society of Clinical Pathology (ASCP) certification. He then took the position of Director of microbiology and immunology laboratories at Milwaukee Children's Hospital (MCH), Milwaukee, WI from 1980 to 1984 where he was a Clinical Assistant Professor at the University of Wisconsin School of Medicine. His work led to the microbiology laboratory's first ASCP certification. While at MCH, he won the first "Steve Hansen" Award from the Southwest Association of Clinical Microbiology (SWACM) for work on detection of urinary tract infections in the pediatric population.
Dr. Marsik went on to take a position at Oral Roberts School of Medicine from 1984 to 1987 as Associate Professor of Microbiology, Pathology, and Internal Medicine and served as the director of the first hospital microbiology laboratory and Infectious Disease Research Institute (IDRI). He obtained ASCP certification for the clinical microbiology laboratory and obtained United States Health and Human Services (HHS) licensure for the IDRI. While at Oral Roberts he continued his research on S. epidermidis and facilitated the research of a graduate student that showed C-reactive protein (CRP) could be used to detect re-occurrence of breast and colon cancer.
From 1987 to 1989 he was the Director of the Clinical Microbiology Laboratory at Crozer Chester Hospital in Chester, PA.
Dr. Marsik went on to work for Becton Dickinson Microbiology Systems in Cockeysville, MD from 1988 to 1996. While Director of Microbiology Media Research and Development he was instrumental in developing bacteriological media and devices for bacterial detection and antimicrobial susceptibility testing. In collaboration with an international colleague, a line of radiation sterilized bacterial culture media for environmental sampling in pharmaceutical manufacturing facilities was made commercially available. He received a patent for the development of a replicate organism detection and counting plate (RODAC) used for microbiological control of surfaces. Dr. Marsik was the recipient of the Becton Dickinson Diagnostic Achievement Award.
From 1996 to 2013, Dr. Marsik worked at the Food and Drug Administration in the Center for Drug Evaluation and Research (CDER) and Generic Drugs, serving as the microbiology team leader. During this time, he was involved in the evaluation of antimicrobial products for the treatment of microbial infections. He did collaborative work with the Division of Dermatology, Center for Veterinary Medicine (CVM), Center for Diagnostics and Radiological Health (CDRH) and the United States Pharmacopeia (USP). Dr. Marsik was the lead microbiologist in CDER for the development of protocols to deal with biothreat agents immediately after 9/11 working with the Center for Disease Control (CDC) and the United States Army Medical Research Institute of Infectious Disease (USAMRID). He was instrumental in developing the microbiology portion of the first FDA "Animal Rule" document. During his work at the FDA he received awards for his individual and team work.
Currently, Dr. Marsik is a consultant and a reviewer for the non-profit international organization CARBX (Combat Antimicrobial Resistance) that is providing scientific and financial assistance to companies and individuals developing drugs or devices that can be used to diagnose and/or treat infections due to bacteria resistant to current antimicrobials.
Dr. Marsik has contributed chapters to books related to clinical and industrial microbiology, authored journal articles and given national and international presentations. He has participated in the development of scientific documents for the United States Pharmacopeia (USP), Clinical and Laboratory Standards Institute (CLSI), American Society for Microbiology (ASM), Parenteral Drug Association (PDA), Safety Pharmacology Society (SPS), and the American Society for Medical Technologists (ASMT).
Dr. Marsik serves as an alumni ambassador for his undergraduate college having been awarded the Carmean Award for this work. He served for 27 years in the United States Army Reserve, retiring as a Lieutenant Colonel in the Medical Service Corp. Dr Marsik's community involvement has been as a volunteer fireman, being a co-founder of the Seminole Trail Volunteer Fire Department in Charlottesville, VA, treasurer of the New Freedom Volunteer Fire Department, New Freedom, PA and serving on adult education committees for his community. Dr. Marsik is married to Pamelia (Ehlers) Marsik, has two daughters Terri Lehman, Kristi McCann, a step-daughter Jacqueline Meyers and five grandchildren. He is listed in several editions of Who's Who in America, Who's Who in Medicine and Healthcare, Who's Who in Science and Engineering, Who's Who in the East and Who's Who in the World.
In recognition of outstanding contributions to his profession and the Marquis Who's Who community, Frederic Marsik, Ph.D., has been featured on the Albert Nelson Marquis Lifetime Achievement website. Please visit www.ltachievers.com for more information about this honor.
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.
# # #